The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Cohen, B. M.
* Articles by Wan, W.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Cohen, B. M.
* Articles by Wan, W.
Related Collections
* Schizophrenia Spectrum Disorders
* Other Neuroleptics
* Molecular Biology
* Other Neuroanatomy

Am J Psychiatry 1996; 153:104-106
Copyright © 1996 by American Psychiatric Association


REGULAR ARTICLES

The thalamus as a site of action of antipsychotic drugs

BM Cohen and W Wan
Mailman Research Center, McLean Hospital, Belmont, MA 02178, USA.

OBJECTIVE: Because recent data suggest that there are abnormalities of the thalamus in schizophrenia, the authors tested the effects of antipsychotic drugs on thalamic sites. METHOD: Nine rats were given acute doses of the typical neuroleptic haloperidol (N = 3), the atypical neuroleptic clozapine (N = 3), or a drug-free vehicle (N = 3). Cellular activation was assessed by using immunohistochemistry to determine expression of the immediate response gene c-fos. RESULTS: Both antipsychotic drugs induced increased Fos immunoreactivity, suggesting increased activity in cells of the midline nuclei of the thalamus. CONCLUSIONS: The shared clinical effects of antipsychotic drugs may be mediated in part through actions on the thalamus.


This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
S. M. Clinton, V. Haroutunian, K. L. Davis, and J. H. Meador-Woodruff
Altered Transcript Expression of NMDA Receptor-Associated Postsynaptic Proteins in the Thalamus of Subjects With Schizophrenia
Am J Psychiatry, June 1, 2003; 160(6): 1100 - 1109.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. M. Thompson, C. Vidal, J. N. Giedd, P. Gochman, J. Blumenthal, R. Nicolson, A. W. Toga, and J. L. Rapoport
From the Cover: Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia
PNAS, September 25, 2001; 98(20): 11650 - 11655.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
H. M. Ibrahim, A. J. Hogg Jr., D. J. Healy, V. Haroutunian, K. L. Davis, and J. H. Meador-Woodruff
Ionotropic Glutamate Receptor Binding and Subunit mRNA Expression in Thalamic Nuclei in Schizophrenia
Am J Psychiatry, November 1, 2000; 157(11): 1811 - 1823.
[Abstract] [Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1996 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org